Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.
Also called NCT05268094
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT05268094
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05268094. Randomized; no masking; primary purpose treatment. Start 2022-06-02 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
- Acronym
- COMPASS
- Condition
- Congenital Heart Disease in Children
- Intervention (Device)
- Ductal Arterial Stent
- Intervention (Procedure)
- Systemic-to-Pulmonary Artery Shunt
- Lead sponsor
- Carelon Research
- Collaborator
- Pediatric Heart Network
Record details
- Record id
cardio:ct-nct05268094- Content hash
7d911515b12e02b284b8f04b5927938f0ae746d1c4ccb1cec7bc5789353a240c